Analysts currently covering Elopak are listed below.
Evaluations and estimations done by the analysts are their own and cannot directly or indirectly be interpreted as an expression of Elopak’s evaluations.
| Firm | Analyst | Phone | |
|---|---|---|---|
| ABG Sundal Collier | Martin Melbye | +47 22 01 61 37 | martin.melbye@abgsc.no |
| Carnegie | Robin Santavirta | +358 4 056 64341 | robin.santavirta@carnegie.fi |
| SEB | Håkon Bøhler Fuglu | +47 92 86 78 13 | hakon.fuglu@seb.no |
| DNB | Niclas Gehin | +47 99 45 70 24 | niclas.gehin@dnb.no |
| Arctic Securities | Jeppe Baardseth | +47 48 21 37 71 | jeppe.baardseth@arctic.com |
| Pareto Securities AS | Marcus Gavelli | + 47 24 02 81 12 | marcus.gavelli@paretosec.com |
| BNP Paribas Exane | Charlie Muir Sands | +44 203 430 8432 | charlie.muir-sands@exanebnpparibas.com |
| Firm |
ABG Sundal Collier
|
Carnegie
|
SEB
|
DNB
|
Arctic Securities
|
Pareto Securities AS
|
BNP Paribas Exane
|
|---|---|---|---|---|---|---|---|
| Analyst |
Martin Melbye
|
Robin Santavirta
|
Håkon Bøhler Fuglu
|
Niclas Gehin
|
Jeppe Baardseth
|
Marcus Gavelli
|
Charlie Muir Sands
|
| Phone |
+47 22 01 61 37
|
+358 4 056 64341
|
+47 92 86 78 13
|
+47 99 45 70 24
|
+47 48 21 37 71
|
+ 47 24 02 81 12
|
+44 203 430 8432
|
|
martin.melbye@abgsc.no
|
robin.santavirta@carnegie.fi
|
hakon.fuglu@seb.no
|
niclas.gehin@dnb.no
|
jeppe.baardseth@arctic.com
|
marcus.gavelli@paretosec.com
|
charlie.muir-sands@exanebnpparibas.com
|
Every quarter ahead of the earnings announcements, Elopak will collect revenue and earnings estimates from the equity analysts currently covering the company. These numbers become a proxy for what the market expects in terms of Elopak’s results.
| Quarter | Collection date | Number of Analysts | Revenue (MEUR) | Adjusted EBITDA (MEUR) |
|---|---|---|---|---|
| Q2 2022 | 15.08.2022 | 6 | 243.9 | 21.9 |
| Q3 2022 | 21.10.2022 | 6 | 256.0 | 29.5 |
| Q4 2022 | 14.02.2023 | 5 | 273.6 | 33.3 |
| Q1 2023 | 26.05.2023 | 5 | 266.1 | 33.1 |
| Q2 2023 | 11.08.2023 | 6 | 290.9 | 39.0 |
| Q3 2023 | 30.10.2023 | 5 | 284.0 | 39.8 |
| Q4 2023 | 09.02.2023 | 5 | 278.8 | 40.8 |
| Q1 2024 | 03.05.2024 | 6 | 293.7 | 42.4 |
| Q2 2024 | 09.08.2024 | 7 | 295.6 | 45.3 |
| Q3 2024 | 24.10.2024 | 7 | 293.3 | 45.4 |
| Quarter |
Q2 2022
|
Q3 2022
|
Q4 2022
|
Q1 2023
|
Q2 2023
|
Q3 2023
|
Q4 2023
|
Q1 2024
|
Q2 2024
|
Q3 2024
|
|---|---|---|---|---|---|---|---|---|---|---|
| Collection date |
15.08.2022
|
21.10.2022
|
14.02.2023
|
26.05.2023
|
11.08.2023
|
30.10.2023
|
09.02.2023
|
03.05.2024
|
09.08.2024
|
24.10.2024
|
| Number of Analysts |
6
|
6
|
5
|
5
|
6
|
5
|
5
|
6
|
7
|
7
|
| Revenue (MEUR) |
243.9
|
256.0
|
273.6
|
266.1
|
290.9
|
284.0
|
278.8
|
293.7
|
295.6
|
293.3
|
| Adjusted EBITDA (MEUR) |
21.9
|
29.5
|
33.3
|
33.1
|
39.0
|
39.8
|
40.8
|
42.4
|
45.3
|
45.4
|
| Year | Collection date | Number of Analysts | Revenue (MEUR) | Adjusted EBITDA (MEUR) |
|---|---|---|---|---|
| 2022 | 21.10.2022 | 6 | 1015 | 113 |
| 2022 | 14.02.2023 | 5 | 1049 | 118 |
| 2023 | 14.02.2023 | 5 | 1124 | 135 |
| 2023 | 26.05.2023 | 5 | 1124 | 137 |
| 2023 | 11.08.2023 | 6 | 1154 | 152 |
| 2023 | 30.20.2023 | 5 | 1127 | 160 |
| 2023 | 09.02.2024 | 5 | 1124 | 171 |
| 2024 | 09.02.2024 | 5 | 1170 | 170 |
| 2024 | 03.05.2024 | 6 | 1178 | 172 |
| 2025 | 03.05.2024 | 6 | 1253 | 185 |
| 2024 | 09.08.2024 | 7 | 1179 | 179 |
| 2025 | 09.08.2024 | 7 | 1257 | 189 |
| 2024 | 24.10.2024 | 7 | 1166 | 180 |
| 2025 | 24.10.2024 | 7 | 1249 | 192 |
| 2026 | 24.10.2024 | 7 | 1360 | 212 |
| Year |
2022
|
2022
|
2023
|
2023
|
2023
|
2023
|
2023
|
2024
|
2024
|
2025
|
2024
|
2025
|
2024
|
2025
|
2026
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collection date |
21.10.2022
|
14.02.2023
|
14.02.2023
|
26.05.2023
|
11.08.2023
|
30.20.2023
|
09.02.2024
|
09.02.2024
|
03.05.2024
|
03.05.2024
|
09.08.2024
|
09.08.2024
|
24.10.2024
|
24.10.2024
|
24.10.2024
|
| Number of Analysts |
6
|
5
|
5
|
5
|
6
|
5
|
5
|
5
|
6
|
6
|
7
|
7
|
7
|
7
|
7
|
| Revenue (MEUR) |
1015
|
1049
|
1124
|
1124
|
1154
|
1127
|
1124
|
1170
|
1178
|
1253
|
1179
|
1257
|
1166
|
1249
|
1360
|
| Adjusted EBITDA (MEUR) |
113
|
118
|
135
|
137
|
152
|
160
|
171
|
170
|
172
|
185
|
179
|
189
|
180
|
192
|
212
|
Any opinions, forecasts, estimates, projections or predictions regarding Elopak’s performance made by the analysts, and thereby also the consensus estimates, are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of Elopak or its management.